Skip to main content

Table 2 Clinical patient characteristics

From: International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26

  

Number

Percent

Treatment status

On treatment

113

36.1

Post treatment

200

63.9

Time since diagnosis [in months]

On treatment

mean 6.7

SD 17.7

Post treatment

mean 5.4

SD 3.4

Histological tumour type

Seminoma

162

62.5

Non-Seminoma

97

37.5

Missing

54

 

Metastases

Metastases Yes

50

18.6

Metastases No

219

81.4

Missing

44

 

Recurrence

Recurrence Yes

39

14.2

Recurrence No

235

85.8

Missing

39

 

Desire for a child

No

143

55.6

Yes

114

44.4

Missing

56

 

Testicular Implant

No

182

75.2

Yes

60

24.8

Missing

71

 

On-treatment Group: Surgery

Surgery No

14

15.9

Surgery Yes

74

84.1

Missing

25

 

On-treatment Group: Chemotherapy

Chemotherapy No

13

14.8

Chemotherapy Yes

75

85.2

Missing

25

 

Post-treatment Group:

Previous Surgery

Surgery No

9

5.5

Surgery Yes

154

94.5

Missing

37

 

Post-treatment Group:

Previous Chemotherapy

Chemotherapy No

60

36.1

Chemotherapy Yes

106

63.9

Missing

34

 

Post-treatment Group:

Previous Radiotherapy

Radiotherapy No

157

94.0

Radiotherapy Yes

10

6.0

Missing

33

 
  1. Percentages are given for valid cases